Parkway Life REIT DPU Shot Up 15%- But Beware!

Parkway Life REIT ("PLREIT") once again announced not just an increase in DPU but a stunning +15.1% for its first quarter distribution. Its last traded market price as at April 30, 2026 was S$4.02 per unit. Despite the fantastic results announcement, I do not think that it is worth it for new investors to foray into this PLREIT at this particular juncture. The recent announced DPU is S$0.0442 per unit for Q1 2026. Annualising this, the dividend yield for PLREIT will be 4.4% (forecast distribution is S$0.1768 per unit per annum). Many blue-chips SREITs such as Mapletree Industrial Trust, Mapletree Pan Asia Commercial Trust or Capitaland Ascendas are actually trading with a much more attractive 6% distribution yield and also way below their Net Asset Value ("NAV") per unit. On the other hand, PLREIT NAV per unit as at March 31, 2026 is only S$2.53 per unit which means that it is trading at a lofty +58.9% premium over its latest NAV per unit.

1. Price Trending Over Past 5 years- Always at a Premium Over its NAV.

Price Chart for PLREIT- Past 5 years 

The best entry price for PLREIT was actually when it was trading at the S$3.50- S$3.60 per unit range 2 years ago Also, PLREIT has been always trading at a premium over its NAV per unit due to it being in the medical sector where demand is deemed to be fairly resilient and that its management has always been delivering increase DPU over the years.

2. Does the Investment Thesis That DPU Is Resilient In Medical Sector True?

I will urge caution on this belief of many retail investors. Look at First REIT and you folks will know what I mean. Being in the medical sector does not mean that earnings will not be impacted. 

The only strong differentiating counter argument here is that PLREIT is way better than First REIT as Singapore has many top medical specialist relative to Indonesia as well as the always strong Singapore dollars compared to declining Rupiah. Nonetheless, it is still a fallacy as there is actually an overly concentration risk of main tenants for PLREIT. Main contributor of revenue is Parkway Hospitals Singapore Pte. Ltd. Again, I will point everyone to First REIT as well as to Elite UK REIT with regard to issues with having a business that has major tenant making up more than 50% of a REIT's revenue.

3. Escalation in Rental Income Increase of around 25% Expected to Start in FY2026.

From the previous S$150Mil AEI initiative at Mount Elizabeth for lease renewal exercise back in 2022, there will be an expected 25% rental uplift that will take effect from FY2026. Even if we take this into effect, the annualised yield will be around 5% which will still be significantly lower relative to the other blue-chip REITs as aforesaid mentioned. So, based on current market price, this is not very attractive.

Parting Thoughts

At the current price, I will be staying far away from PLREIT. I also find it strange that a number of retail investors view PLREIT as a "stable bond fund". PLREIT is never a bond fund. It is an equity instrument and thus comes with higher risk profile similar to other stock investments. Ok, that's all for my thoughts sharing for today, have a great week ahead!